Retour
Fourchette du Jour
114,77 €
116,47 €
Fourchette 52 Semaines
73,31 €
125,14 €
Volume
6 391 503
Moyenne 50J / 200J
115,65 €
/
94,64 €
Clôture Précédente
114,18 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (625 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 15,7 | 14,0 |
| P/B | 5,4 | 2,4 |
| ROE % | 36,9 | 11,4 |
| Net Margin % | 28,1 | 10,1 |
| Rev Growth 5Y % | 7,5 | 7,0 |
| D/E | 1,0 | 0,5 |
Objectif de Cours des Analystes
Hold
128,54 €
+11.1%
Low: 100,00 €
High: 150,00 €
P/E Prévisionnel
22,6
BPA Prévisionnel
5,12 €
Croissance BPA (est.)
+0,0%
CA Est.
67 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
10,16 €
9,87 € – 10,37 €
|
74 B | 5 |
| FY2029 |
10,36 €
10,07 € – 10,58 €
|
75 B | 2 |
| FY2028 |
10,77 €
8,85 € – 13,13 €
|
75 B | 7 |
Points Clés
Revenue grew 7,49% annually over 5 years — modest growth
ROE of 36,91% indicates high profitability
Net margin of 28,08% shows strong profitability
Generating 12,36B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,18%
Capital efficient — spends only 6,33% of revenue on capex
Croissance
Revenue Growth (5Y)
7,49%
Revenue (1Y)1,31%
Earnings (1Y)6,64%
FCF Growth (3Y)16,27%
Qualité
Return on Equity
36,91%
ROIC19,47%
Net Margin28,08%
Op. Margin41,19%
Sécurité
Debt / Equity
0,96
Current Ratio1,54
Interest Coverage0,00
Valorisation
P/E Ratio
15,67
P/B Ratio5,44
EV/EBITDA12,02
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,31% | Revenue Growth (3Y) | 3,99% |
| Earnings Growth (1Y) | 6,64% | Earnings Growth (3Y) | 607,18% |
| Revenue Growth (5Y) | 7,49% | Earnings Growth (5Y) | 8,75% |
| Profitability | |||
| Revenue (TTM) | 65,01B | Net Income (TTM) | 18,25B |
| ROE | 36,91% | ROA | 13,34% |
| Gross Margin | 81,50% | Operating Margin | 41,19% |
| Net Margin | 28,08% | Free Cash Flow (TTM) | 12,36B |
| ROIC | 19,47% | FCF Growth (3Y) | 16,27% |
| Safety | |||
| Debt / Equity | 0,96 | Current Ratio | 1,54 |
| Interest Coverage | 0,00 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 15,67 | P/B Ratio | 5,44 |
| P/S Ratio | 4,40 | PEG Ratio | 1,88 |
| EV/EBITDA | 12,02 | Dividend Yield | 0,03% |
| Market Cap | 285,98B | Enterprise Value | 321,95B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65,01B | 64,17B | 60,12B | 59,28B | 48,70B |
| Net Income | 18,25B | 17,12B | 365,00M | 14,52B | 13,05B |
| EPS (Diluted) | 7,28 | 6,74 | 0,14 | 5,71 | 5,14 |
| Gross Profit | 52,98B | 48,98B | 43,99B | 41,87B | 35,08B |
| Operating Income | 26,78B | 20,22B | 2,95B | 18,28B | 13,20B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 136,87B | 117,11B | 106,68B | 109,16B | 105,69B |
| Total Liabilities | 84,20B | 70,73B | 69,04B | 63,10B | 67,44B |
| Shareholders' Equity | 52,61B | 46,31B | 37,58B | 45,99B | 38,18B |
| Total Debt | 50,53B | 38,27B | 36,27B | 31,99B | 34,63B |
| Cash & Equivalents | 14,57B | 13,24B | 6,84B | 12,69B | 8,10B |
| Current Assets | 43,52B | 38,78B | 32,17B | 35,72B | 30,27B |
| Current Liabilities | 28,33B | 28,42B | 25,69B | 24,24B | 23,87B |